Although AML cell expression of the CXCR2 receptor is associated with an adverse prognosis in human AML [88,89,90,91], it is not known whether soluble DEK contributes to this together with the several CXCL chemokines that also bind to the receptor. This evidence concerns the gene DEK and acute myeloid leukemia.